Bayer Takes License For Homocysteine Assay

Law360, New York (October 25, 2004, 12:00 AM EDT) -- A unit of drug maker Bayer Group has agreed to take a license for a technology covering homocysteine assays, following Competitive Technologies’ victory in its five-year patent infringement lawsuit against LabCorp over the same technology.

Under the accord reached, Bayer was granted a license under the Competitive Technologies patent and will pay royalties on sales of Bayer homocysteine assays, the companies said in a joint release.

Customers who purchase Bayer homocysteine assays will be covered by the Bayer license from Competitive Technologies. Bayer customers such as...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.